40
Participants
Start Date
March 31, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
June 30, 2025
High dose
Patients will receive a high dose of sesame paste or flour (1200 mg of sesame protein) mixed with apple mousse (supposing child tolerates apple). For the transparency of the study all patients will receive the same commercially prepared apple product
Low dose
Patients will receive a low dose of sesame paste or flour (300 mg of sesame protein) mixed with apple mousse (supposing child tolerates apple). For the transparency of the study all patients will receive the same commercially prepared apple product
RECRUITING
Katarzyna Grzela, Warsaw
Medical University of Warsaw
OTHER